Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Newer advances in the Management of Atopic Dermatitis & the role of PDE4 inhibitor
Recent advances in the management of atopic dermatitis (AD) have revolutionized treatment options, particularly for patients with moderate to severe disease. Traditional therapies, like topical corticosteroids and emollients, often provide limited relief in severe cases. Newer treatments, such as biologics (e.g., dupilumab) and small molecule inhibitors, have emerged, targeting the underlying immune pathways involved in AD. These innovations focus on reducing inflammation, improving skin barrier function, and controlling symptoms more effectively over the long term.
Phosphodiesterase 4 (PDE4) inhibitors, such as crisaborole, represent a significant advancement in treating AD. By inhibiting the PDE4 enzyme, these drugs reduce the production of inflammatory cytokines, thus alleviating symptoms like itching and redness. PDE4 inhibitors are particularly beneficial for patients who require steroid-sparing options or for those who have milder forms of AD that need long-term management. Their targeted mechanism offers a safer profile with fewer side effects, making them an attractive option in the evolving landscape of AD therapy.
Therefore, get an overall knowledge of newer advances in the management of atopic dermatitis & the role of PDE4 inhibitors. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
2.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
3.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
4.
A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma
5.
Squeezing through tiny blood vessels may trigger melanoma cells to spread
1.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
2.
Everything You Need to Know About Leiomyomas: A Comprehensive Guide
3.
The Importance of Corrected Calcium Levels in Managing Health Conditions
4.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation